Mutations in PTEN, a tumour suppressor gene, occur at a high frequency in human cancer. The gene encodes a phosphatase that acts in signalling pathways to negatively regulate cell growth. Inactivation of PTEN leads to increased cell proliferation and reduced cell death, resulting in tumour formation. Until now, it has proven difficult to induce complete PTEN loss in different tissues simultaneously because of the protein’s crucial role in development. Here, Mirantes and colleagues describe an inducible PTEN knockout mouse model. Tamoxifen-induced PTEN deletion resulted in the rapid development of hyperplasias and neoplasias in endometrial, prostrate and thyroid tissue and administration of a known anti-tumoral drug, everolimus, hindered carcinogenesis. These data validate the model as a valuable tool for investigating PTEN-negative cancers and for testing the efficacy of new therapies. Page 710
An inducible knockout mouse model for PTEN cancers Open Access
An inducible knockout mouse model for PTEN cancers. Dis Model Mech 1 May 2013; 6 (3): 556. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists